Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2022-10-31 00:00:00 ET · period of report 2022-10-27 · accession 0001387131-22-010982 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-10-31 | 2022-10-27 | RXRX | Mubadala Investment Co PJSC | 10% | A - Grant | $9.80 | +2.55M | 11.29M | +29% | +$25.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-10-27 | A | A | 2,551,020 | $9.80 | 11,291,937 | I See Explanation of Responses | — | — | (F1) On October 24, 2022, Recursion Pharmaceuticals, Inc. (the "Issuer") entered into a securities purchase agreement with Fifteenth Investment Company LLC, pursuant to which the Issuer agreed to issue, for an aggregate purchase price of $24,999,996.00, 2,551,020 shares of Class A Common Stock, $0.00001 par value per share (the "PIPE Shares") of the Issuer's common stock at a price of $9.80 per share. (F5) Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. (F2) Consists of (i) 11,291,937 shares held of record by Fifteenth Investment Company LLC and (ii) 0 shares held of record by Thirty Fifth Investment Company LLC, as a result of a transfer of 5,963,140 shares to Fifteenth Investment Company LLC. Both Fifteenth Investment Company LLC and Thirty Fifth Investment Company LLC are wholly owned subsidiaries of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi. (F4) Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. |